{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T14:28:47Z","timestamp":1672324127072},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s00105-012-2331-1","type":"journal-article","created":{"date-parts":[[2012,6,18]],"date-time":"2012-06-18T16:00:47Z","timestamp":1340035247000},"page":"456-461","source":"Crossref","is-referenced-by-count":3,"title":["Fokale Hyperhidrose"],"prefix":"10.1007","volume":"63","author":[{"given":"B.","family":"Rzany","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,6,14]]},"reference":[{"key":"2331_CR1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00403-009-0928-8","volume":"301","author":"Augustin","year":"2009","unstructured":"Augustin M, Radtke MA et al (2009) The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases. Arch Dermatol Res 301(8):561\u2013571","journal-title":"Arch Dermatol Res"},{"key":"2331_CR2","first-page":"107","volume":"14","author":"Augustin","year":"2004","unstructured":"Augustin M, Lange S et al (2004) Validation of a comprehensive Freiburg Life Quality Assessment (FLQA) core questionnaire and development of a threshold system. Eur J Dermatol 14(2):107\u2013113","journal-title":"Eur J Dermatol"},{"key":"2331_CR3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1468-3083.2009.03563.x","volume":"24","author":"Bronsard","year":"2010","unstructured":"Bronsard V, Paul C, Prey S et al (2010) What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature. J Eur Acad Dermatol Venereol 24(Suppl 2):17\u201322 (Review)","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2331_CR4","first-page":"303","volume":"15","author":"Castells","year":"1987","unstructured":"Castells Rodellas A, Moragon Gordon M, Ramirez Bosca A (1987) Effect of bornaprine in localized hyperhidrosis. Med Cutan Ibero Lat Am 15:303\u2013305","journal-title":"Med Cutan Ibero Lat Am"},{"key":"2331_CR5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.thorsurg.2008.01.009","volume":"18","author":"Cetindag","year":"2008","unstructured":"Cetindag IB, Boley TM et al (2008) Long-term results and quality-of-life measures in the management of hyperhidrosis. Thorac Surg Clin 18(2):217\u2013222","journal-title":"Thorac Surg Clin"},{"key":"2331_CR6","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/1523-1747.ep12365600","volume":"107","author":"Chren","year":"1996","unstructured":"Chren MM, Lasek RJ et al (1996) Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol United States 107:707\u2013713","journal-title":"J Invest Dermatol United States"},{"key":"2331_CR7","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jpsychores.2009.05.006","volume":"68","author":"Devins","year":"2010","unstructured":"Devins GM (2010) Using the illness intrusiveness ratings scale to understand health-related quality of life in chronic disease. J Psychosom Res 68(6):591\u2013602","journal-title":"J Psychosom Res"},{"key":"2331_CR8","unstructured":"ESCOP (2003) \u201eSalviae folium.\u201c Monographs on the medicinal uses of plant drugs. European Scientific Cooperative on Phytotherapy, Exeter, U.K"},{"key":"2331_CR9","unstructured":"Figarella I, Tr\u00e9chot P, Girard F et al (2001) Prevalence of hyperhidrosis in a population treated by beta-blocker. Ann Dermatol Venereol 128(8\u20139):877\u2013881"},{"key":"2331_CR10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"Finlay","year":"1994","unstructured":"Finlay AY, Khan GK (1994) Dermatology Life Quality Index (DLQI) \u2013 a simple practical measure for routine clinical use. Clin Exp Dermatol 19(3):210\u2013216","journal-title":"Clin Exp Dermatol"},{"key":"2331_CR11","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1097\/00005650-199112000-00007","volume":"29","author":"Gafni","year":"1991","unstructured":"Gafni A (1991) Willingness-to-pay as a measure of benefits. Relevant questions in the context of public decisionmaking about health care programs. Med Care 29:1246\u20131252","journal-title":"Med Care"},{"key":"2331_CR12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1439-0353.2004.04765.x","volume":"2","author":"Hund","year":"2004","unstructured":"Hund M, Sinkgraven R, Rzany B (2004) Randomized, placebo-controlled, double blind clinical trial for the evaluation of the efficacy and safety of oral methantheliniumbromide (Vagantin) in the treatment of focal hyperhidrosis. J Dtsch Dermatol Ges 2:343\u2013349","journal-title":"J Dtsch Dermatol Ges"},{"key":"2331_CR13","first-page":"P51","volume":"50","author":"Jonathan","year":"2004","unstructured":"Jonathan WK, Nina E et al (2004) Validity and reliability of the hyperhidrosis disease severity scale (HDSS)1. All authors are employees of Allergan, Inc. J Am Acad Dermatol 50(3):P51","journal-title":"J Am Acad Dermatol"},{"key":"2331_CR14","unstructured":"Kamudoni P, Salek S, M\u00fcller B, M\u00fcller C (im Druck) A review of quality of life and patient centred disease severity measures in hyperhidrosis (zur Ver\u00f6ffentlichung eingereicht)"},{"key":"2331_CR15","unstructured":"Keller S, Sekons MD et al (2001) A novel scale for assessing quality of life following bilateral endoscopic thoracic sympathectomy for palmer and plantar hyperhidrosis. 4th International Symposium on Sympathetic Surgery. Tampere, Finland (Abstract O-22)"},{"key":"2331_CR16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.JNR.0000387485.78685.1e","volume":"12","author":"Kuo","year":"2004","unstructured":"Kuo CH, Yen M et al (2004) Developing an instrument to measure quality of life of patients with hyperhidrosis. J Nurs Res 12(1):21\u201330","journal-title":"J Nurs Res"},{"key":"2331_CR17","doi-asserted-by":"crossref","unstructured":"McDowell I (2006) Measuring health: a guide to rating scales and questionnaires. Oxford University Press, Oxford","DOI":"10.1093\/acprof:oso\/9780195165678.001.0001"},{"key":"2331_CR18","unstructured":"M\u00fcller C, Augustin M (im Druck) Willingness-to-pay and patients defined benefits in the treatment of hyperhidrosis \u2013 results from the first German health services research pilot study in hyperhidrosis. (zur Ver\u00f6ffentlichung eingereicht)"},{"key":"2331_CR19","unstructured":"M\u00fcller C, Berensmeier A, Hamm H et al (im Druck) Efficacy and safety of methantheline bromide (Vagantin\u00ae) in axillary and palmar hyperhidrosis: results from a multicenter, randomized, placebo-controlled trial (zur Ver\u00f6ffentlichung eingereicht)"},{"key":"2331_CR20","doi-asserted-by":"crossref","unstructured":"M\u00fcller C, L\u00f6tsch J, Giessmann T et al (2012) Relative bioavailability and pharmacodynamic effects of methantheline compared with atropine in healthy subjects. Eur J Clin Pharmacol (zur Ver\u00f6ffentlichung angenommen)","DOI":"10.1007\/s00228-012-1286-6"},{"key":"2331_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00403-010-1080-1","volume":"303","author":"Mrowietz","year":"2010","unstructured":"Mrowietz U, Kragballe K, Reich K et al (2010) Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res 303(1):1\u201310","journal-title":"Arch Dermatol Res"},{"key":"2331_CR22","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1046\/j.1365-2133.2002.05059.x","volume":"147","author":"Naumann","year":"2002","unstructured":"Naumann MK, Hamm H, Lowe NJ, Botox Hyperhidrosis Clinical Study Group (2002) Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial. Br J Dermatol 147(6):1218\u20131226","journal-title":"Br J Dermatol"},{"key":"2331_CR23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10353-005-0148-1","volume":"37","author":"Panhofer","year":"2005","unstructured":"Panhofer P, Neumayer C et al (2005) A survey and validation guide for health-related quality-of-life status in surgical treatment of hyperhidrosis. Eur Surg 37(3):143\u2013152","journal-title":"Eur Surg"},{"key":"2331_CR24","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/bjs.5304","volume":"93","author":"Panhofer","year":"2006","unstructured":"Panhofer P, Zacherl J, Jakesz R et al (2006) Improved quality of life after sympathetic block for upper limb hyperhidrosis. Br J Surg 93(5):582\u2013586","journal-title":"Br J Surg"},{"key":"2331_CR25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10227-002-0145-y","volume":"7","author":"Parks","year":"2003","unstructured":"Parks L, Balkrishnan R, Hamel-Gariepy L et al (2003) The importance of skin disease as assessed by \u201ewillingness-to-pay\u201c. J Cutan Med Surg 7:369\u2013371","journal-title":"J Cutan Med Surg"},{"key":"2331_CR26","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00105-003-0559-5","volume":"54","author":"Rzany","year":"2003","unstructured":"Rzany B, Hund M (2003) Fokale Hyperhidrose. Hautarzt 54:767\u2013780","journal-title":"Hautarzt"},{"key":"2331_CR27","unstructured":"Schroyens F (2005) SYSNTHESIS \u2013 Repertorium homeopathicum syntheticum, Edition 9.1. Privatinstitut f\u00fcr hom\u00f6opathische Dokumentation, Greifenberg"},{"key":"2331_CR28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jaad.2003.12.040","volume":"51","author":"Strutton","year":"2004","unstructured":"Strutton DR, Kowalski JW, Glaser DA, Stang PE (2004) US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol 51(2):241\u2013248","journal-title":"J Am Acad Dermatol"},{"key":"2331_CR29","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1524-4725.2002.01159.x","volume":"28","author":"Tan","year":"2002","unstructured":"Tan SR, Solish N (2002) Long-term efficacy and quality of life in the treatment of focal hyperhidrosis with botulinum toxin A. Dermatol Surg 28(6):495\u2013499","journal-title":"Dermatol Surg"},{"key":"2331_CR30","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2133.2004.06334.x","volume":"152","author":"Weber","year":"2005","unstructured":"Weber A, Heger S, Sinkgraven R et al (2005) Psychosocial aspects of patients with focal hyperhidrosis. Marked reduction of social phobia, anxiety and depression and increased quality of life after treatment with botulinum toxin A. Br J Dermatol 152(2):342\u2013345","journal-title":"Br J Dermatol"},{"key":"2331_CR31","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.avsg.2011.06.007","volume":"25","author":"Wolosker","year":"2011","unstructured":"Wolosker N, Campos JR de, Kauffman P et al (2011) The use of oxybutynin for treating axillary hyperhidrosis. Ann Vasc Surg 25:1057\u20131062","journal-title":"Ann Vasc Surg"},{"key":"2331_CR32","doi-asserted-by":"crossref","unstructured":"Wolosker N, Campos JR de, Kauffman P, Puech-Le\u00e3o P (2012) A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis. J Vasc Surg [Epub ahead of print]","DOI":"10.1016\/j.jvs.2011.12.039"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-012-2331-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-012-2331-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-012-2331-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T03:37:56Z","timestamp":1558582676000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-012-2331-1"}},"subtitle":["Lebensqualit\u00e4t, sozio\u00f6konomische Bedeutung und der Einsatz interner medikament\u00f6ser Therapien"],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["2331"],"URL":"https:\/\/doi.org\/10.1007\/s00105-012-2331-1","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}